Rachel King is a trailblazer in biotech, a venture capitalist turned co-founder and CEO, now turned industry leader. As CEO of the Biotechnology Innovation Organization (BIO), King has focused in ...
INmune Bio is working with the FDA to define a path forward for the therapy based on these results. According to the company, its cash position stood at approximately $27.7 million as of September 30, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results